NVST Envista Holdings Corp

$25.89 +4.19%

Healthcare · Dental Equipment & Supplies

Envista Holdings Corp (NVST) is a healthcare company in the Dental Equipment & Supplies industry, with a market capitalization of $4.2 billion. Shares last traded at $25.89, 14.7% below their 52-week high. Over the past year the stock is up 40.6%. NVST trades at a price-to-earnings ratio of 89.64, above the Healthcare median of 25.98. Net profit margin is 1.7%, above the peer median of 0.0%. Revenue grew 8.3% year over year.

Market Cap

$4.2B

Shares Out

162.7M

EPS (TTM)

$0.67

P/E Ratio

38.64

P/S Ratio

1.55

P/B Ratio

1.37

Dividend / Share

—

Dividend Yield

—

52-Week High

$30.36

52-Week Low

$18.25

Volume

202,818

Avg Vol (3m)

198,493.27

Performance

+5.70%

+12.35%

+2.51%

+18.17%

YTD

+19.42%

+40.55%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

65.50

SMA (50)

$25.02

SMA (200)

$23.46

Price vs SMA50

+3.49%

Price vs SMA200

+10.37%

ATR (14)

$0.99

Financials

Revenue

$2.7B

Net Income

$47M

Gross Margin

54.7%

Operating Margin

7.9%

Net Margin

1.7%

Return on Equity

1.5%

Return on Assets

0.8%

Current Ratio

2.44

Debt / Equity

0.47

Revenue Growth (YoY)

+8.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.23	2026-05-06
FY 2025	$0.28	2026-02-12
Q3 2025	$0.08	2025-10-30
Q2 2025	$0.26	2025-07-31
Q1 2026	$0.10	2026-05-06
FY 2025	$-6.50	2026-02-12

Full earnings history →

Healthcare peers

NVST vs 14 sector peers (Healthcare), by market cap.

P/E vs peers

89.64 / 25.98 med

+245% premium

P/S vs peers

1.55 / 2.59 med

-40% discount

Net margin vs peers

1.7% / 0.0% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.